With the advances made in genetic testing for familial BC and OVC in state laboratories in SA, it has the potential to contribute immensely to the identification of high-risk BRCA1/2 and non-BRCA germline actionable variants in patients. The gene discussed is BRCA1; the disease is breast cancer.